Pamela L Kunz

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Carcinoid and neuroendocrine tumors: building on success
    Pamela L Kunz
    Stanford Cancer Center, Stanford, CA
    J Clin Oncol 33:1855-63. 2015
  2. pmc A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male
    Stephen M Wanta
    Georgetown University School of Medicine, Washington, DC
    Rare Tumors 3:e45. 2011
  3. pmc Consensus guidelines for the management and treatment of neuroendocrine tumors
    Pamela L Kunz
    Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 5826, USA
    Pancreas 42:557-77. 2013
  4. ncbi request reprint Long-term survivors of gastric cancer: a California population-based study
    Pamela L Kunz
    Stanford University School of Medicine, Stanford Cancer Center, 875 Blake Wilbur Dr, Stanford, CA 94025 5826, USA
    J Clin Oncol 30:3507-15. 2012
  5. doi request reprint Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumors
    Motaz Qadan
    Department of Surgery, Stanford University Hospital and Clinics, Stanford, CA
    J Am Coll Surg 218:188-95. 2014
  6. doi request reprint Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?
    Manali I Patel
    Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
    Ann Surg Oncol 20:1631-8. 2013
  7. doi request reprint Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis
    George A Poultsides
    Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Ann Surg Oncol 19:2295-303. 2012
  8. doi request reprint HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment
    Pamela L Kunz
    Department of Medicine Oncology, Stanford University, Stanford, CA 94305, USA
    Appl Immunohistochem Mol Morphol 20:13-24. 2012
  9. doi request reprint Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity
    Erqi L Pollom
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
    Int J Radiat Oncol Biol Phys 90:918-25. 2014
  10. pmc Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness
    David J Worhunsky
    Department of Surgery, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
    HPB (Oxford) 16:304-11. 2014

Collaborators

Detail Information

Publications15

  1. doi request reprint Carcinoid and neuroendocrine tumors: building on success
    Pamela L Kunz
    Stanford Cancer Center, Stanford, CA
    J Clin Oncol 33:1855-63. 2015
    ..This comprehensive review article summarizes recent advances in the field of neuroendocrine tumors and places them into context for best management practices. ..
  2. pmc A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male
    Stephen M Wanta
    Georgetown University School of Medicine, Washington, DC
    Rare Tumors 3:e45. 2011
    ..We also performed a review of the literature and found three similar cases, however gene mutation analysis was not performed....
  3. pmc Consensus guidelines for the management and treatment of neuroendocrine tumors
    Pamela L Kunz
    Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 5826, USA
    Pancreas 42:557-77. 2013
    ..Here, we present a set of consensus tables intended to complement these guidelines and serve as a quick, accessible reference for the practicing physician...
  4. ncbi request reprint Long-term survivors of gastric cancer: a California population-based study
    Pamela L Kunz
    Stanford University School of Medicine, Stanford Cancer Center, 875 Blake Wilbur Dr, Stanford, CA 94025 5826, USA
    J Clin Oncol 30:3507-15. 2012
    ..In the United States, gastric cancer is rapidly fatal with a 25% 5-year survival. Of the few patients who survive, little is known about their demographic, clinical, and tumor characteristics...
  5. doi request reprint Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumors
    Motaz Qadan
    Department of Surgery, Stanford University Hospital and Clinics, Stanford, CA
    J Am Coll Surg 218:188-95. 2014
    ..Currently, the American Joint Committee on Cancer (AJCC) recommends use of the pancreatic adenocarcinoma staging system for PNETs. We sought to explore the prognostic usefulness of the pancreatic adenocarcinoma staging system for PNETs...
  6. doi request reprint Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?
    Manali I Patel
    Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
    Ann Surg Oncol 20:1631-8. 2013
    ..We sought to validate the new system on a U.S. population database...
  7. doi request reprint Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis
    George A Poultsides
    Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Ann Surg Oncol 19:2295-303. 2012
    ..Specifically, the prevalence and prognostic significance of radiographic calcifications in these tumors remains unclear...
  8. doi request reprint HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment
    Pamela L Kunz
    Department of Medicine Oncology, Stanford University, Stanford, CA 94305, USA
    Appl Immunohistochem Mol Morphol 20:13-24. 2012
    ....
  9. doi request reprint Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity
    Erqi L Pollom
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
    Int J Radiat Oncol Biol Phys 90:918-25. 2014
    ..We report updated outcomes of single- versus multifraction stereotactic body radiation therapy (SBRT) for unresectable pancreatic adenocarcinoma...
  10. pmc Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness
    David J Worhunsky
    Department of Surgery, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
    HPB (Oxford) 16:304-11. 2014
    ..However, a subset of these tumours can be hypoenhancing. The prognostic significance of the CT appearance of these tumors remains unclear...
  11. doi request reprint Postradiotherapy CA19-9 kinetics correlate with outcomes in patients with pancreatic adenocarcinoma
    David B Shultz
    From the Department of Radiation Oncology, and Division of Oncology, Department of Medicine, Stanford University and Stanford Cancer Institute, Stanford, CA
    Pancreas 43:777-83. 2014
    ..We sought to determine if carbohydrate antigen 19-9 (CA19-9 ) nadir (nCA19-9), time to nadir (TTN), and doubling time (DT) after radiotherapy (RT) correlate with outcomes in pancreatic ductal adenocarcinoma...
  12. pmc Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis
    Stephanie T Chang
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
    J Transl Med 7:105. 2009
    ..Proximity ligation assay (PLA) is a highly sensitive technique for multiplex detection of biomarkers in plasma with little or no interfering background signal...
  13. ncbi request reprint Everolimus causing severe hypertriglyceridemia and acute pancreatitis
    Somasundaram Subramaniam
    Stanford Cancer Institute, Stanford, California, USA
    J Natl Compr Canc Netw 11:5-9. 2013
    ..Because there are increasing indications for the use of everolimus, prescribing oncologists must be cognizant of the common and serious side effects...
  14. doi request reprint Capecitabine-induced chest pain relieved by diltiazem
    Andrew P Ambrosy
    Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
    Am J Cardiol 110:1623-6. 2012
    ..In conclusion, guidelines for the evaluation of and therapy for capecitabine-induced chest pain are proposed...
  15. pmc Advances in the treatment of gastroenteropancreatic neuroendocrine tumors
    Pamela L Kunz
    Stanford University Medical Center, CA, USA
    Clin Exp Gastroenterol 3:79-86. 2010
    ..The rarity of these tumors, their resistance to standard chemotherapy, and the excellent performance status of most of these patients, make a strong argument for consideration of novel therapeutic trials...